Clinical Trial Update: TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy and Tolerability. The TIKlet Study

View source ↗

Summary

The TIKlet Study evaluated tyrosine kinase inhibitors for chronic myeloid leukemia and has completed, reporting data on efficacy and tolerability. Sponsor: Univ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Tyrosine kinase inhibitors

Snippet

Sponsor: University of Pisa | Conditions: Chronic Myeloid Leukemia | Status: COMPLETED